Attached files
| file | filename |
|---|---|
| 8-K/A - AMENDMENT NO. 1 TO CURRENT REPORT - Helix Technologies, Inc. | f8k060118a1_helixtcsinc.htm |
| EX-99.3 - UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEETS AND STATEMENTS OF OPERATIO - Helix Technologies, Inc. | f8k060118a1ex99-3_helixtcs.htm |
| EX-99.2 - UNAUDITED BALANCE SHEET, INCOME STATEMENT AND STATEMENT OF CASH FLOWS OF BIOTRAC - Helix Technologies, Inc. | f8k060118a1ex99-2_helixtcs.htm |
| EX-99.1 - AUDITED BALANCE SHEET, INCOME STATEMENT AND STATEMENT OF CASH FLOWS OF BIOTRACKT - Helix Technologies, Inc. | f8k060118a1ex99-1_helixtcs.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-221995) of Helix TCS, Inc. of our report dated August 13, 2018 on our audits of the financial statements of Bio-Tech Medical Software, Inc. as of December 31, 2017 and 2016 and for each of the years in the two-year period ended December 31, 2017, which report is included in this Current Report on Form 8-K/A of Helix TCS, Inc. to be filed on or about August 13, 2018. Our report includes an explanatory paragraph about the existence of substantial doubt concerning Bio-Tech Medical Software, Inc.’s ability to continue as a going concern.
/s/ EisnerAmper LLP
EISNERAMPER LLP
Fort Lauderdale, Florida
August 13, 2018